Print Issue: December 01, 2010

Update affirms breast cancer treatment guidelines

The Clinical Practice Guide­lines in Oncology for Breast Cancer, published by NCCN, have been updated to affirm the existing recommendation regarding the use of bevacizumab (Avastin) for the treatment of metastatic breast cancer.

Next post in In the News